The Mikron Group has exceeded the previous year's good results and thus confirmed the pleasing results for the first half of 2023. Strong demand in the pharmaceutical and medical technology industries and the continued good performance in all three divisions were the key factors behind this pleasing development. Both business segments succeeded in significantly increasing their annual net sales once again.
The Mikron Group has exceeded the previous year's good results and thus confirmed the pleasing results for the first half of 2023. Strong demand in the pharmaceutical and medical technology industries and the continued good performance in all three divisions were the key factors behind this pleasing development. Both business segments succeeded in significantly increasing their annual net sales once again.